Stay updated on IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial

Sign up to get notified when there's something new on the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.5.2 is now displayed on the Record History page, replacing the previous v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T10:39:49.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.5.0 is now shown as the current revision, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T17:21:33.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision label in the page footer updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T14:56:38.000Z thumbnail image
  6. Check
    78 days ago
    Change Detected
    Summary
    The page now shows a new Revision: v3.4.2, and the previous funding-status notice and Revision: v3.4.1 have been removed.
    Difference
    0.2%
    Check dated 2026-02-11T06:17:01.000Z thumbnail image
  7. Check
    85 days ago
    Change Detected
    Summary
    The history shows a site-wide funding notice and a new page revision to v3.4.1, replacing v3.4.0.
    Difference
    0.2%
    Check dated 2026-02-04T04:57:12.000Z thumbnail image
  8. Check
    92 days ago
    Change Detected
    Summary
    Added a Show glossary toggle and clarified color-coded change indicators (green for additions, red for deletions) on the history page. Updated the revision label to v3.4.0, replacing the previous v3.3.4.
    Difference
    0.3%
    Check dated 2026-01-28T03:18:03.000Z thumbnail image

Stay in the know with updates to IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IL-15 Combo with Nivolumab & Ipilimumab in Refractory Cancers Clinical Trial page.